Anthony H Nguyen

Array ( [id] => 4204107 [patent_doc_number] => 06077701 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Ikk.beta. regulates transcription factors' [patent_app_type] => 1 [patent_app_number] => 9/222734 [patent_app_country] => US [patent_app_date] => 1998-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12770 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077701.pdf [firstpage_image] =>[orig_patent_app_number] => 222734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231105 [patent_doc_number] => 06692943 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Persephin and related growth factors' [patent_app_type] => B1 [patent_app_number] => 09/220527 [patent_app_country] => US [patent_app_date] => 1998-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 47602 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692943.pdf [firstpage_image] =>[orig_patent_app_number] => 09220527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1205229 [patent_doc_number] => 06716600 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-06 [patent_title] => 'Persephin and related growth factors' [patent_app_type] => B1 [patent_app_number] => 09/220407 [patent_app_country] => US [patent_app_date] => 1998-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 32 [patent_no_of_words] => 57220 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716600.pdf [firstpage_image] =>[orig_patent_app_number] => 09220407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4108059 [patent_doc_number] => 06022874 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Piperazine based cytofectins' [patent_app_type] => 1 [patent_app_number] => 9/219758 [patent_app_country] => US [patent_app_date] => 1998-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 10050 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 414 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022874.pdf [firstpage_image] =>[orig_patent_app_number] => 219758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141064 [patent_doc_number] => 06030834 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Human IKK-beta DNA constructs and cells' [patent_app_type] => 1 [patent_app_number] => 9/215131 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12433 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030834.pdf [firstpage_image] =>[orig_patent_app_number] => 215131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4275912 [patent_doc_number] => 06323395 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Nucleotide sequences of maize and soybean .beta.-Ketoacyl-Acyl Carrier Protein Synthase II and their use in the regulation of fatty acid content of oil' [patent_app_type] => 1 [patent_app_number] => 9/212609 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31619 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323395.pdf [firstpage_image] =>[orig_patent_app_number] => 212609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151513 [patent_doc_number] => 06107041 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Detection and modulation of IAPS for the diagnosis and treatment of proliferative disease' [patent_app_type] => 1 [patent_app_number] => 9/212971 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 42 [patent_no_of_words] => 26896 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107041.pdf [firstpage_image] =>[orig_patent_app_number] => 212971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4309321 [patent_doc_number] => 06316258 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Methods for preventing and treating fibrotic diseases resulting from accumulation of excess extracellular matrix induced by TGF.beta. using renin inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/211916 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 9695 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316258.pdf [firstpage_image] =>[orig_patent_app_number] => 211916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 953826 [patent_doc_number] => 06958239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-25 [patent_title] => 'Three component chimeric antisense oligonucleotides' [patent_app_type] => utility [patent_app_number] => 09/211794 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4436 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/958/06958239.pdf [firstpage_image] =>[orig_patent_app_number] => 09211794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4007027 [patent_doc_number] => 05962265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Human signal transduction serine/threonine kinase' [patent_app_type] => 1 [patent_app_number] => 9/211930 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 1 [patent_no_of_words] => 28797 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962265.pdf [firstpage_image] =>[orig_patent_app_number] => 211930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4159902 [patent_doc_number] => 06114517 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Methods of modulating tumor necrosis factor .alpha.-induced expression of cell adhesion molecules' [patent_app_type] => 1 [patent_app_number] => 9/209668 [patent_app_country] => US [patent_app_date] => 1998-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 28488 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114517.pdf [firstpage_image] =>[orig_patent_app_number] => 209668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943468 [patent_doc_number] => 05981732 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Antisense modulation of G-alpha-13 expression' [patent_app_type] => 1 [patent_app_number] => 9/205860 [patent_app_country] => US [patent_app_date] => 1998-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27506 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981732.pdf [firstpage_image] =>[orig_patent_app_number] => 205860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4905832 [patent_doc_number] => 20080115246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Nucleic Acid Molecules and Other Molecules Associated with Plants' [patent_app_type] => utility [patent_app_number] => 09/199129 [patent_app_country] => US [patent_app_date] => 1998-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25128 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20080115246.pdf [firstpage_image] =>[orig_patent_app_number] => 09199129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986293 [patent_doc_number] => 05959097 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Antisense modulation of MEK2 expression' [patent_app_type] => 1 [patent_app_number] => 9/197378 [patent_app_country] => US [patent_app_date] => 1998-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24824 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/959/05959097.pdf [firstpage_image] =>[orig_patent_app_number] => 197378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950016 [patent_doc_number] => 05977341 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Antisense modulation of inhibitor-kappa B kinase-beta expression' [patent_app_type] => 1 [patent_app_number] => 9/197008 [patent_app_country] => US [patent_app_date] => 1998-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26283 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977341.pdf [firstpage_image] =>[orig_patent_app_number] => 197008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013708 [patent_doc_number] => 05962673 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Antisense modulation of inhibitor-kappa B kinase-alpha expression' [patent_app_type] => 1 [patent_app_number] => 9/197360 [patent_app_country] => US [patent_app_date] => 1998-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26153 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962673.pdf [firstpage_image] =>[orig_patent_app_number] => 197360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4117506 [patent_doc_number] => 06046319 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Antisense oligodeoxynucleotides regulating expression of TNF-.alpha.' [patent_app_type] => 1 [patent_app_number] => 9/176862 [patent_app_country] => US [patent_app_date] => 1998-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 12790 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046319.pdf [firstpage_image] =>[orig_patent_app_number] => 176862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1593793 [patent_doc_number] => 06383746 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Functional promoter for CCR5' [patent_app_type] => B1 [patent_app_number] => 09/177437 [patent_app_country] => US [patent_app_date] => 1998-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19089 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383746.pdf [firstpage_image] =>[orig_patent_app_number] => 09177437 [rel_patent_id] =>[rel_patent_doc_number] =>)